Total Health

Anthony S. Fauci, M.D.

Director, NIAID

Anthony S. Fauci, M.D. is director of the National Institute of Allergy and Infectious Diseases (NIAID) at the U.S. National Institutes of Health, where he oversees an extensive research portfolio focused on infectious and immune-mediated diseases. He serves as one of the key advisors to the White House and Department of Health and Human Services on global HIV/AIDS issues, and on initiatives to bolster medical and public health preparedness against emerging infectious disease threats. He is the winner of numerous prestigious awards including the Presidential Medal of Freedom, the National Medal of Science and the Lasker Award for Public Service.

Arianna Huffington

Chief Executive Officer, Thrive Global

Arianna Huffington is the founder and CEO of Thrive Global, the founder of The Huffington Post, and the author of 15 books, including, most recently, Thrive and The Sleep Revolution. In 2016, she launched Thrive Global, a leading behavior change tech company with the mission of changing the way we work and live by ending the collective delusion that burnout is the price we must pay for success.

She has been named to Time Magazine's list of the world’s 100 most influential people and the Forbes Most Powerful Women list. Originally from Greece, she moved to England when she was 16 and graduated from Cambridge University with an M.A. in economics. At 21, she became president of the famed debating society, the Cambridge Union.

She serves on numerous boards, including Onex and The B Team.

Her last two books, Thrive: The Third Metric to Redefining Success and Creating a Life of Well-Being, Wisdom, and Wonder and The Sleep Revolution: Transforming Your Life, One Night At A Time, both became instant international bestsellers.

Anne Wojcicki

CEO and co-founder, 23andMe

Anne co-founded 23andMe in 2006 after a decade spent in healthcare investing, focused primarily on biotechnology companies. Her hope was to empower consumers with access to their own genetic information and to create a way to generate more personalized information so that commercial and academic researchers could better understand and develop new drugs and diagnostics. Presently, 23andMe has built one of the world’s largest databases of individual genetic information. Its novel, web-based research approach allows for the rapid recruitment of participants to many genome-wide association studies at once, reducing the time and money needed to make new discoveries, and the company has created a proven and standardized resource for finding new genetic association and confirming genetic loci discovered by others. Under Anne’s leadership 23andMe has made significant advances in bringing personalized medicine directly to the public. Anne graduated from Yale University with a BS in Biology. Getting access to and understanding her own genetic information had always been one of her ambitions.

Michael J. Dowling

President and Chief Executive Officer, Northwell Health

Michael J. Dowling is President and Chief Executive Officer of Northwell Health (formerly the North Shore-LIJ Health System). With 21 hospitals, more than 450 outpatient physician practices and a full complement of long-term care services, Northwell Health is one of the nation’s largest health systems, with nearly $8 billion in annual revenue. Michael served in New York State government for 12 years, including seven years as state director of Health, Education and Human Services and deputy secretary to the governor. He was also commissioner of the New York State Department of Social Services. Earlier this month, Mr. Dowling spoke to the audience of the HEP Annual Meeting about issues affecting large hospital systems, the healthcare industry in general, and the Hofstra Northwell School of Medicine.

Michael A. Slubowski

President and Chief Executive Officer, Trinity Health

Mike Slubowski, president and chief executive officer, Trinity Health provides executive leadership to the 22-state, 92-hospital Catholic health system, serves on the Trinity Health Board of Directors, and has full accountability for the overall achievement, advancement, and success of the system.

Immediately prior to this role, Slubowski served as the system's president and chief operating officer, overseeing all system operations, and focusing on ensuring that people, processes, IT systems and resources were in place to achieve successful operations.

Slubowski's more than 40 years as a health care executive include tenures as president and CEO of Sisters of Charity of Leavenworth Health System, in Colorado, as president, Health Networks, for Trinity Health before its 2013 merger with Catholic Health East, and in executive leadership positions at health systems including Henry Ford Health System in Detroit, Michigan; Samaritan Health Services in Phoenix, Arizona; and Providence Hospital in Southfield, Michigan.

Slubowski holds a bachelor's degree in business administration and a master’s degree in business administration from Wayne State University in Detroit, Michigan. He completed advanced health care leadership training through an Advanced Leadership Institute conducted by the University of Michigan School of Business and sponsored by the National Center for Healthcare Leadership. He also holds fellowships in the American College of Healthcare Executives and the American College of Medical Practice Executives.

Paul Stoffels

Vice Chairman of the Executive Committee and Chief Scientific Officer, Johnson & Johnson

Paul Stoffels is a visionary leader who inspires and drives transformational innovation to bring years of life and quality of life to millions of people around the world.

Paul spearheads the Johnson & Johnson research and product pipeline by leading teams across all our sectors to set the companywide innovation agenda, discovering and developing transformational healthcare solutions. He also is responsible for the safety of all products of the Johnson & Johnson Family of Companies worldwide, and steers the company’s global public health strategy to make innovative medicines and technologies accessible in the world’s most vulnerable communities and resource-poor settings.

Paul’s commitment to fueling innovation and finding the best science, wherever it exists, is the driving force behind the launch of Johnson & Johnson Innovation in 2013, which he now leads to foster science and technology through strategic partnerships, licensing and acquisitions. Paul also oversees JJDC, the oldest corporate venture fund in the life science industry.

Previously, in his role as Worldwide Chairman, Pharmaceuticals, Paul led the transformation of the pharmaceutical research and development pipeline for Janssen Pharmaceutical Companies of Johnson & Johnson, driving a fundamental shift in the R&D paradigm that is now a model in the industry for productivity and innovation. Under his leadership, Janssen rejuvenated its pipeline, launching multiple new medicines and making a difference for people all over the world.

Prior to this, Paul held various R&D leadership roles within the pharmaceutical sector of Johnson & Johnson. He joined Johnson & Johnson in 2002 with the acquisition of Virco and Tibotec, where he was Chief Executive Officer of Virco and Chairman of Tibotec, and led the development of several breakthrough products for the treatment of HIV that helped to transform this devastating disease from a death sentence to a chronic and treatable condition.

Paul studied Medicine at the University of Diepenbeek and the University of Antwerp in Belgium and Infectious Diseases and Tropical Medicine at the Institute of Tropical Medicine in Antwerp, Belgium. He began his career as a physician in Africa, focusing on HIV and tropical diseases research.

Greg A. Adams

Chairman and Chief Executive Officer, Kaiser Permanente

Greg A. Adams is the chairman and CEO of Kaiser Foundation Health Plan, Inc. and Hospitals.

Adams assumed the role of chairman and CEO in December 2019.

A nationally recognized leader and a champion of health care transformation, improving access, and pushing for better health outcomes, Adams, since his time with Kaiser Permanente, has been driving the comprehensive work focused on growing the organization’s membership, improving affordability for members, and transforming and expanding access to care.

Adams has 30 years of leadership experience as a senior health care executive and has played an integral role in leading the transformation and improvement of patient care outcomes at Kaiser Permanente. In addition, Adams has been a key leader in driving the organization’s mission of providing high-quality, affordable care and coverage; strengthening the culture; and ensuring Kaiser Permanente continues to be a great place to work.

Prior to his current role, Adams served as executive vice president and group president, with direct responsibility for health plan and hospital operations in all 8 Kaiser Permanente regions, serving 12.4 million members and operating 39 hospitals and 715 medical office facilities. Adams' accountabilities included co-leading Enterprise Shared Services to serve the operational needs of the regions and leading Kaiser Permanente’s national Medicare care delivery strategy. Prior to that, he was named regional president of Kaiser Permanente for Northern California in April 2008. In July 2013, he was appointed executive vice president.

Adams is a member of the board of directors for America’s Health Insurance Plans and is both a governor and steward within the Global Health and Healthcare Community at the World Economic Forum. Additionally, Adams is a member of the Business Roundtable, the National Association of Health Services Executives, and The Executive Leadership Council. He also serves on the board of directors for the Los Angeles Philharmonic Association. He is a past member of the California Chamber of Commerce board of directors and the California Hospital Association’s board of trustees.

Adams has a bachelor’s degree from Oglethorpe University in Atlanta and graduate degree from Wichita State University.

George Yancopoulos

Chief Scientific Officer, Regeneron

George D. Yancopoulos, MD, PhD, has built and managed Regeneron alongside Dr. Schleifer since 1989. Dr. Yancopoulos is currently President and Chief Scientific Officer and has served on the board since 2001. Dr. Yancopoulos, along with key members of his team, is the principal inventor of Regeneron’s seven FDA-approved drugs and foundational technologies, including the TRAP technology, VelociGene® and VelocImmune®. He has been named an Ernst & Young Entrepreneur of the Year and has been pivotal in creating the science-driven, collaborative and highly-productive R&D culture at Regeneron. This unique environment has earned the company widespread recognition, including repeatedly being named one of the "most innovative companies in the world" by Forbes magazine. Dr. Yancopoulos was the 11th most highly cited scientist in the world in the 1990s, and in 2004 he was elected to be a member of the National Academy of Sciences. Dr. Yancopoulos attended the Bronx High School of Science and received his MD and PhD from Columbia University.

Dr. Anton Decker

President, International, Mayo Clinic

G. Anton Decker, MBBCh, is president of International at Mayo Clinic, a not-for-profit, academic health system. With a workforce of 70,000, Mayo Clinic earns $14 billion in annual revenue while caring for more than 1.2 million patients each year from all 50 states and more than 140 countries.

Prior to returning to Mayo Clinic in 2019, Dr. Decker was president of Health Innovation for Bon Secours Mercy Health, an $8 billion net revenue international health system with 48 hospitals and 60,000 staff. He also served as chief clinical officer for Mercy Health, president of Mercy Health Physicians, chief medical officer and board chair for Banner Medical Group, and board chair for Banner Health Network.

Dr. Decker, a gastroenterologist, has authored more than 60 peerreviewed papers and has been an invited speaker at numerous institutions and meetings, most with a focus on health care economics. He is the chair of the American Gastroenterological Association Practice Management and Economics Committee.

Born in South Africa, Dr. Decker completed medical school at the University of the Witwatersrand, Johannesburg, and trained at Mayo Clinic College of Medicine and Science as a resident and fellow. He also earned a master’s degree in health administration.

Having worked in four countries, Dr. Decker brings a global perspective to collaboration with people from all backgrounds and experiences.

Noubar Afeyan

Founder and Chief Executive Officer, Flagship Pioneering

More info coming soon.

Michael Neidorff

Chairman, President and Chief Executive Officer, Centene Corporation

Michael Neidorff is Centene Corporation's chairman, president and chief executive officer. A recognized leader in the industry, he is committed to building a multi-national healthcare enterprise while upholding Centene's local approach to healthcare. He demonstrates a history of successfully implementing programs and services under Medicaid, Medicare, and commercial managed care. Under his leadership, Centene has grown from a $40 million corporation to a publicly traded (NYSE: CNC), FORTUNE® 100, diversified, healthcare enterprise.

Michael Neidorff became president and chief executive officer of Centene Corporation in 1996. The company established operations in all 50 states – to become the largest Medicaid managed care organization in the U.S. and the top insurer in the Health Insurance Marketplace. Revenues are expected to exceed $110 billion in 2020. Centene now delivers high-quality and accessible healthcare to nearly 1 in 15 individuals across the nation.

Centene provides accessible, cost-effective coverage to the rising number of under-insured and uninsured people in communities across the U.S. Under Mr. Neidorff's leadership, Centene has expanded from operating Medicaid health plans solely in Wisconsin and Indiana, to operations in every state, serving more than 23 million managed care and TRICARE eligible individuals.

Mr. Neidorff's record of transformative leadership is proven in the healthcare industry. In 1985, he started Physicians Health Plan of Greater St. Louis, a subsidiary of UnitedHealth Group. He served as the president and chief executive officer from 1985-1995, and grew the plan to be one of UnitedHealth Group's most successful and profitable plans in the country. From 1995-1996, he served as the regional vice president of Coventry Health Care, Inc., a publicly traded managed care organization, and as the president and chief executive officer of one of its subsidiaries, Group Health Plan Inc. in St. Louis. He also served in international senior executive positions at Miles Laboratories/Bayer AG.

Michael Neidorff dedicates significant time to civic organizations. He is a board member of the National Urban League and served as its chairman from 2014-2019. In 2015, he was inducted into the Hall of Fame for Junior Achievement of Greater St. Louis. He served as a member of the board of directors for the Greater St. Louis Boy Scouts of America since 1990, serving as Pathfinder district chair, vice chairman and chairman of the Special Needs Committee, vice president of Finance, and council president. Mr. Neidorff is a member of the board of trustees for Trinity University in San Antonio, Texas, his alma mater, and previously served as chairman of the board.

Jason Gorevic

Chief Executive Officer, Teladoc Health

Jason Gorevic is chief executive officer and a member of Teladoc Health's board of directors. Since taking the reins in 2009, he has led Teladoc Health to its position today as the world leader in virtual care, achieving significant growth in revenue, membership, and telehealth utilization. Under his leadership the company has established a proven track record of successfully shaping the market and driving healthcare transformation by executing on the strategic vision, delivering award-winning innovation, and effectively integrating each corporate acquisition.

Nationally recognized as a thought leader and trailblazer in the virtual delivery of healthcare, Mr. Gorevic is fueled by a passion for improving healthcare outcomes and providing universal access to care. His extensive career in healthcare began at Oxford Health, and he has also held executive leadership roles at WellPoint, Inc. (now Anthem, Inc.) and Empire BlueCross BlueShield.

He holds a Bachelor of Arts in International Relations from the University of Pennsylvania.

Dr. Susan Turney

Chief Executive Officer, Marshfield Clinic Health System

Dr. Susan L. Turney is the CEO of Marshfield Clinic Health System (MCHS), taking on that role September 1, 2014. Through its entities, MCHS provides patient care, research, education, health care technology and health insurance for Wisconsin and beyond.

She is recognized as a national thought leader in health care and expert in strategic planning, executive management and external relations. She is sought out as a speaker by national organizations to discuss the business of this industry and is a member of the Modern Healthcare CEO Power Panel, including representatives of the nation’s largest hospital, physician practice, insurer, trade association and think tank organizations.  She was named to Modern Healthcare’s list of 50 Most Influential Physician/Clinical Executives from 2012-2016, 2018, 2019, 2020 and on its list of 100 Most Influential People in Healthcare in 2012- 2014, and 2019. Dr. Turney received the Wisconsin Medical Society’s Directors Award in 2017.  She was named to Becker’s Hospital Review’s list of 27 Female Physician Executives to know in 2018 and named Distinguished Leader by MGMA-ACMPE in 2018. Dr. Turney was named to Becker’s Hospital Review’s list of 105 Physician Leaders to Know in 2019.

Prior to her current MCHS position, Dr. Turney was President and CEO, Medical Group Management Association (MGMA), the leading association for medical group practice administrators and executives, from 2011-14. She was CEO and Executive VP of the Wisconsin Medical Society from 2004-11.  She is a Fellow in the American College of Medical Practice Executives (FACMPE), having earned that distinction in 2005.

For 22 years, from 1982-2004, Dr. Turney was an internal medicine physician at Marshfield Clinic, serving in education and leadership roles and as medical director for Patient Financial Services from 1995 to 2004.

Dr. Turney, a native of Mellen, Wisconsin, graduated from Northland College, Ashland, Wisconsin; and the University of Wisconsin-Madison School of Medicine and Public Health. She completed her internal medicine residency at Marshfield Clinic/Ministry Saint Joseph’s Hospital, Marshfield, Wisconsin, and earned a masters degree in administrative medicine from UW-Madison.

Dr. Laurie Glimcher

President, Dana-Farber Cancer Institute

Laurie H. Glimcher, MD, is the President and CEO of the Dana-Farber Cancer Institute, Director of the Dana-Farber/Harvard CancerCenter, and the Richard and Susan Smith Professor of Medicine at Harvard Medical School. Previously, she was the Stephen and Suzanne Weiss Dean and Professor of Medicine of Weill Cornell Medicine and Provost for Medical Affairs of Cornell University. Dr. Glimcher is a distinguished immunologist, widely renowned for her work in one of the most promising areas of cancer research.

Nancy Howell Agee

President and Chief Executive Officer, Carilion Clinic

Nancy Howell Agee is president and chief executive officer of Carilion Clinic, a nearly $2 billion not-for-profit integrated health system headquartered in Roanoke, Virginia, serving more than 1 million people in Virginia and West Virginia.

Carilion Clinic includes seven hospitals ranging from the third largest in Virginia to mid-sized community and small rural or critical access hospitals. Carilion also operates complementary business lines, including home health, imaging services, pharmacies and free-standing surgical clinics and has a large physician group with more than 1,000 employed physicians.

Before becoming CEO in 2011, Ms. Agee served as executive vice president and chief operating officer. During her tenure as COO, she co-led Carilion’s reorganization from a collection of hospitals to a fully integrated, physician-led clinic. The reorganization resulted in a partnership with Virginia Tech to create an allopathic medical school and research institute.

Ms. Agee is recognized nationally as a health care leader and currently serves as chair of the American Hospital Association, a membership organization representing the nation’s 5,000 hospitals and health care systems. She was named one of Modern Healthcare’s top 25 women in health care in 2017 and one of the national magazine’s 100 most influential people in health care in 2016 and 2017. She is a former member of The Joint Commission’s Board of Commissioners and past chair of the Virginia Hospital & Healthcare Association and the Virginia Center for Health Innovation.

Warner Thomas

President and Chief Executive Officer, Ochsner Health

Warner Thomas was named President and CEO of Ochsner Health in 2012 after previously serving as President and Chief Operating Officer from 1998-2012. He is the CEO of Louisiana’s largest non-profit academic health system and its largest private employer.

Today, Ochsner employs more than 26,000 employees and more than1,500 employed physicians in over 90 medical specialties and subspecialties and conducts more than 750 clinical research studies. The system coordinates and provides clinical and hospital patient care across the Gulf South region through its 40 owned, managed and affiliated hospitals and specialty hospitals, and more than 115 health and urgent care centers.

Ochsner is the only Louisiana hospital recognized by U.S. News & World Report as a “Best Hospital” across one adult specialty category and one pediatric specialty and every year cares for patients from all 50 states and more than 70 countries. 

Under Thomas’s leadership, Ochsner has expanded access to care in Louisiana and the Gulf South as well as become a national and global destination for healthcare. Ochsner Health is committed to supporting the growing and unique needs of the communities it serves and providing specialty services where and when patients need it. Some of this is accomplished in partnership with other strong healthcare organizations across the Gulf South and provides the opportunity for Ochsner to scale patient-centered technology and other solutions to bring advanced care closer to home.

Thomas has been instrumental in developing a population health focus at Ochsner, delivering programs and resources that empower patients to effectively manage chronic conditions while also maintaining focus on preventive measures, screenings and education to help people stay well and avoid preventable disease. He also worked to launch innovationOchsner in 2015, an Ochsner lab designed to create health advancements to address national issues including chronic disease management, as well as to support and partner with companies working to revolutionize patient-centered care. Internally, Thomas spearheaded the creation of the Ochsner Learning Institute which provides free professional education for all Ochsner leaders to better prepare them to confront challenges, seek opportunity and ignite enthusiasm around best practices in healthcare.

Thomas is a board member of the American Hospital Association. He is a former member of the Medicare Payment Advisory Commission where he advised Congress on issues affecting Medicare. He has served as Chairman of the American Hospital Association Section for Health Systems Governing Council and is a past member of both the Board of the American Medical Group Association and the Association of American Medical Colleges Advisory Panel for Health Care and Council of Teaching Hospitals. Additionally, Thomas is a fellow of the American College of Healthcare Executives, a Louisiana Hospital Association board member and a member of both the Young Presidents Organization and New Orleans Business Council.

Thomas received an undergraduate degree in accounting and computer information systems from New Hampshire College in Manchester, N.H., and his Master of Business Administration degree in 1994 from Boston University Graduate School of Management. He is also a certified public accountant.

Thomas is a recipient of the Boy Scouts of America Distinguished Citizen Award, the Anti-Defamation League 2018 A.I. Botnick Torch of Liberty Award, and was named the 2017 CEO of the Year by Biz New Orleans magazine, one of Glassdoor Top CEOs in 2018 and one of Ernst &Young’s Entrepreneur Of The Year® in the Healthcare & Related Services category for the Gulf Coast Area in 2019.  He was also named as one of Modern Healthcare’s Top 100 Most Influential People in Healthcare for 2020.

Dr. Jaewon Ryu

President and Chief Executive Officer, Geisinger Health

Dr. Jaewon Ryu is Geisinger’s president and chief executive officer. He came to Geisinger as the executive vice president and chief medical officer in 2016, and in that capacity, he has overseen all aspects of patient care at Geisinger, working to improve the quality, affordability and experience of care delivered across the enterprise.

During his tenure at Geisinger, Dr. Ryu has cultivated a spirit of innovation and transformation across the organization, driving new approaches to some of healthcare’s most complex problems. These include initiatives like primary care redesign; Geisinger at Home, which brings healthcare services to patients in their home; and 65 Forward, our senior-focused, concierge healthcare centers. All of these are examples of Dr. Ryu’s commitment to making health easier by improving outcomes, engagement and affordability. This dedication to innovation for the health of our communities earned Dr. Ryu a top 20 spot on Modern Healthcare’s Most Influential Clinical Executives list for 2019.

Dr. Ryu was previously at Humana, where he was president of integrated care delivery and responsible for Humana’s owned and joint ventured care delivery assets, including a management services organization (MSO) assisting affiliated practices to adopt population health under value-based reimbursement methodologies.

Prior to Humana, Dr. Ryu held various leadership roles at the University of Illinois Hospital & Health Sciences System, Kaiser Permanente (where he also practiced as an emergency medicine physician), and in government, at the Centers for Medicare and Medicaid Services, and as a White House Fellow at the Department of Veterans Affairs. He was also a practicing corporate healthcare attorney with the international firm McDermott, Will & Emery.

Dr. Ryu was appointed to the Medicare Payment Advisory Commission (MedPAC), an independent body legislatively tasked with advising Congress on payment and other policies governing health plans and providers serving Medicare beneficiaries. He has previously served in various other advisory roles, including board positions with My Health Direct Inc., a provider of digital care coordination solutions (acquired by Experian), as well as MCCI and JenCare, both clinic/MSO organizations managing the financing and delivery of care for Medicare Advantage members under full-risk payment models. He has also served on the Board of Directors of the White House Fellows Foundation and Association.

Dr. Ryu earned his BA degree from Yale University and his MD and JD from the University of Chicago. He completed his residency training in emergency medicine at Harbor-UCLA Medical Center.

Dr. Gary Kaplan

Chairman and Chief Executive Officer, Virginia Mason Health

Gary S. Kaplan, MD, FACP, FACMPE, FACPE, has served as chairman and CEO of the Virginia Mason Health System in Seattle since 2000. He is also a practicing internal medicine physician at Virginia Mason.

Dr. Kaplan received a degree in medicine from the University of Michigan and is board certified in internal medicine. He completed his internal medicine residency at Virginia Mason and served as chief resident in 1980 and 1981. He is a Fellow of the American College of Physicians (FACP), the American College of Medical Practice Executives (FACMPE) and the American College of Physician Executives (FACPE). He is recognized as one of the most influential physician executives in health care.

Dr. Kaplan has served as chair of the Institute for Healthcare Improvement (IHI) Board of Directors, and is currently chair of the IHI Lucian Leape Institute.

He was a founding member of Health CEOs for Health Reform and has held leadership positions with numerous organizations, including the Medical Group Management Association and the Washington Healthcare Forum.

Marvin O’Quinn

Chief Operating Officer, CommonSpirit Health

As President and Chief Operating Officer of CommonSpirit Health, which was formed by the merger of Catholic Health Initiatives and Dignity Health in 2019, Marvin O’Quinn is responsible for integrating the operations of the newly formed health system. By implementing a progressive & innovative operating model, Mr. O’Quinn is advancing the company’s mission to provide high-quality health care to diverse communities in the 21 states CommonSpirit serves.

Mr. O’Quinn has dedicated his 37-year career in the health care industry to driving a shift from sick care to well care and advocating for vulnerable populations. In his current role, he leads system operations across CommonSpirit’s varied divisions and markets to integrate process management and achieve performance improvements in supply chain and ambulatory operations.

Previously, as Senior Executive Vice President and Chief Operations Officer of Dignity Health, Mr. O’Quinn focused on providing excellent patient care by ensuring operational efficiency, fostering leadership accountability, and identifying operational improvement opportunities. He has also held senior leadership positions with numerous health systems, including Jackson Health System in Miami, New York Presbyterian Health System in New York City, and Providence Medical Center in Portland.

Mr. O’Quinn holds a master’s degree in Health Administration and a bachelor’s degree in Science and Biology from the University of Washington in Seattle.

Deborah Kilpatrick

Chief Executive Officer, Evidation Health

Deborah is the Co-Chief Executive Officer and Executive Chair of Evidation Health. She is a Director for both the Task Force for Global Health and Sleep Number (NASDAQ: SNBR), serves on the Georgia Tech and Cal Poly Engineering Advisory Boards, and is a Fellow of the American Institute of Medical and Biological Engineering. Earlier in her career, Deborah held leadership roles at CardioDx and Guidant Corporation, where she was Research Fellow, Director of R&D, and Director of New Ventures in its Vascular Intervention Division prior to its acquisition by Boston Scientific. Deborah is a co-founder of the MedtechVision Conference, now held annually in Silicon Valley. She holds BS, MS and PhD degrees in mechanical engineering with a bioengineering focus from Georgia Tech.

Laura S. Kaiser

President and Chief Executive Officer, SSM Health

As President/Chief Executive Officer of SSM Health, Laura S. Kaiser, FACHE, leads a Catholic not-for-profit health system serving communities across the Midwest through a robust and fully integrated health care delivery system. Headquartered in St. Louis, SSM Health includes 23 hospitals, more than 290 physician offices and other outpatient and virtual care services, 10 post-acute facilities, comprehensive home care and hospice services, a pharmacy benefit company, a health insurance company and an accountable care organization. The nearly 40,000 employees and 11,000 providers at SSM Health are committed to delivering exceptional health care services and revealing God’s healing presence to everyone they serve.

Ms. Kaiser joined SSM Health as President/CEO in May 2017, bringing 30+ years of experience in health care strategy, improving clinical quality, fueling innovation, managing operational performance and growth, leading change management and successfully facilitating health care integration.

Ms. Kaiser previously served as Executive Vice President and Chief Operating Officer for Intermountain Healthcare in Salt Lake City, UT. She also served at Ascension Health in a number of senior leadership roles including Regional Executive for the Gulf Coast/ Florida region and President/CEO at Sacred Heart Health System in Pensacola, FL. Ms. Kaiser currently serves on several boards, including the American Hospital Association Health System Council, the Catholic Health Association, the Healthcare Leadership Council, Nuance Communications, Embold Health, the Scottsdale Institute and Civic Progress.

She earned a Bachelor of Science from the University of Missouri, a Master of Business Administration and a Master of Healthcare Administration from Saint Louis University.

Ms. Kaiser is a Fellow of the American College of Healthcare Executives, and in 2018 and 2019 was named one of the “100 Most Influential People in Healthcare” by Modern Healthcare magazine.

Stephen K. Klasko

Chief Executive Officer, Jefferson Health

Dr. Stephen Klasko is an advocate for a transformation of health care and higher education. He has been a pioneer in using technology to build health assurance and equity – especially as we emerge from the Covid-19 crisis.

His new books are Un-Healthcare: A Manifesto for Health Assurance, with Hemant Taneja, and Patient No Longer: Why Healthcare Must Deliver the Care Experience that Consumers Want and Expect. His 2018 book is Bless This Mess: A Picture Story of Healthcare in America.

As President and CEO of Philadelphia-based Thomas Jefferson University and Jefferson Health since 2013, he has led one of the nation’s fastest growing academic health institutions based on his vision of re-imagining health care and higher education.

Under his leadership, Jefferson Health expanded from three hospitals to 14. His 2017 merger of Thomas Jefferson University with Philadelphia University created a pre-eminent professional university that includes fashion, design, architecture and health.

In 2020, he was named the first Distinguished Fellow of the World Economic Forum, and co-chairs the WEF Board of Stewards for The Future of the Digital Economy and New Value Creation.

President Klasko has served as dean of two medical colleges, and leader of three academic health enterprises before becoming President and CEO at Jefferson. For three years he has been listed among the Top 100 most influential people by Modern Healthcare - in 2018 he tied for #2.

His work on healthcare in a digital economy includes his 2009 collaboration with Apple Inc on digital media in healthcare, the 2012 building of one of the nation's largest medical simulation centers (CAMLS), and the development at Jefferson of his vision of "healthcare with no address." He is working with several digital health companies on the vision of "health assurance," using new technology to keep people well, instead of waiting to provide sick care.

Dr. Milind Kamkolkar

Chief Digital Officer, Cellarity

Milind Kamkolkar is the CDO of Cellarity, where the “D” is both Digital and Data. At Cellarity, digital is the operating model and data is a core value driver of the company. With this integrated approach, Milind is leading Cellarity’s diverse AI and Digital organization, which implements machine learning science on a digital biology landscape to explore new clinical hypotheses that can alter cell behaviors. His dream was to build a therapeutics company that integrated digital and data as a business-as-usual, interdisciplinary and non-hierarchical model. For the first time in the life sciences industry, this is happening at Cellarity.

Milind joined Cellarity from Sanofi where he was the first enterprise Chief Data Officer in the pharmaceutical industry. Milind’s focus was transforming Sanofi from a data-generation organization into a data-driven organization, to empower the lives of patients and enrich the value Sanofi delivered to customers. The approach was drawn from his tenure at Novartis where he was the Global Head of Data Science and AI in Digital Medicines.

Milind is an intrapreneur and entrepreneur with a career spanning big pharma, big and boutique consulting and numerous technology and software startup companies focused at the intersection of health, technology and data. His relentless commitment to excellence across the value chain of pharma has led to multi-billion-dollar impacts by blending digital insights and partnership approaches across industries to solve complex human health problems at scale.

Milind is a featured speaker (TEDx), Business Transformation Top 150 Leader and thought leader in digital health, AI and big data. Milind has served as a board advisor and mentor to numerous startups, founders and VC firms focused on entering the life science space through digital, data or AI. He has served as an Honorary Lecturer for Physician Entrepreneurship at BartsX, Faculty at Exponential Medicine and a Former Special Advisor to the UN Global Compact Sustainable Development Goals program.

Milind holds a B.Sc. from the University of Sydney and M.S. from Thomas Jefferson University.

Angela Hwang

Group President, Pfizer Biopharmaceuticals Group

Angela Hwang is a member of Pfizer’s Executive Team and Group President of the Pfizer Biopharmaceuticals Group, which comprises 80% of Pfizer’s revenues. Her organization of 26,000 colleagues is responsible for bringing over 600 innovative medicines and products to patients. In 2019, more than 434 million people benefited from a Pfizer Biopharma medicine or vaccine to improve their health and, in some cases, save their lives. Altogether, Pfizer Biopharma generated around $40 billion in 2019 revenues.

As Group President of Pfizer Biopharma, Angela leads 7 commercial business units, reaching patients in more than 125 countries. Together, these businesses strive to deliver transformational medicines that address major global health priorities in cancer, rare disease, inflammation & immunology, primary care, infectious diseases, and preventative care with vaccines.

Angela has been with Pfizer for 23 years, working across all geographies and therapeutic areas. She is motivated by the common purpose that all Pfizer colleagues share, to bring breakthroughs to patients, regardless of where they are in the world. Her childhood as an Asian girl growing up in apartheid South Africa, defined her worldview and underscored the importance of equity in everything she does today.

Angela sits on the Boards of Directors at UPS, the global leader in supply chain logistics and package delivery, EFPIA (European Federation of Pharmaceutical Industries and Associations), as well as the Pfizer Foundation, a charitable organization that addresses global health challenges. She has also been active in industry groups such as BIO, where she previously co-chaired the Vaccines Policy Committee. In 2019, she was named in Crain’s Notable Women in Healthcare list.

Having always been curious about transformation and the art of the possible, in 2019, Angela launched Diverse Perspectives, a podcast series where she hosts global thought leaders pioneering change across a variety of industries. You can learn more about Diverse Perspectives here, and subscribe on iTunes, Spotify, and other streaming platforms.

Angela received her Bachelor of Science in Microbiology and Biochemistry from the University of Cape Town and MBA from Cornell University. She is a wife and proud mom to a teenage son and daughter, and a strong advocate for women’s leadership and sustainable global health equity.

Kathy Giusti

Founder & Chief Mission Officer, Multiple Myeloma Research Foundation

Kathy Giusti, a multiple myeloma patient, is the Founder of the Multiple Myeloma Research Foundation (MMRF) and the Multiple Myeloma Research Consortium (MMRC). She is also the Chief Mission Officer of the MMRF. Kathy is the Henry & Allison McCance Family Senior Fellow at Harvard Business School, where she serves as Faculty Co-Chair of the HBS Kraft Precision Medicine Accelerator. Kathy has more than two decades of experience in the pharmaceutical industry, previously holding senior positions at G.D. Searle and Merck.

Since founding the MMRF in 1998, Kathy has become a widely respected leader in establishing innovative, collaborative research models in the areas of tissue banking, genomics, and clinical trials. These models are dramatically accelerating the pace at which lifesaving treatments are brought to patients and are building an end-to-end solution in precision medicine. Today, she is recognized as a pioneer of precision medicine, a champion of data sharing, and a strong advocate for patient engagement.

In 2016, Kathy was named Faculty Co-Chair of the Harvard Business School (HBS) Kraft Precision Medicine Accelerator, a $20 million program endowed by Robert Kraft and the Kraft Family Foundation. Under her leadership, the HBS Kraft Precision Medicine Accelerator convenes best-in-class leaders from science, business, and technology to identify and solve challenges slowing the advancement of precision medicine. The HBS Kraft PM Accelerator disseminates best practices and models to overcome these challenges, and ultimately enables faster adoption of high-impact innovations.

Kathy has earned numerous prestigious awards and recognitions, including being named 1 of 3 Top Business Leaders Disrupting Medicine by Fortune Magazine and #19 on Fortune’s World’s 50 Greatest Leaders list. She was also named one of the world’s 100 Most Influential People by TIME magazine. Kathy received the Open Science Champion of Change award by the White House. In addition, she has been honored with the American Association for Cancer Research Centennial Medal for Distinguished Public Service and the Healthcare Businesswomen’s Association’s Woman of the Year Award.

Kathy serves on the advisory boards of Verily and Verily’s Project Baseline and is a member of the Harvard Business School (HBS) Health Advisory Board. She a Member of the FasterCures Non-Profit Council. Kathy previously served on President Obama’s 2015 Precision Medicine Initiative Working Group, the President’s Council of Advisors on Science and Technology (PCAST), National Cancer Advisory Board (NCAB), and the National Cancer Policy Board (NCBP).

Kathy has been featured on the Today Show, NBC Nightly News, CBS Evening News, Fox News, CNN, and Bloomberg. Her efforts have also been profiled by Fortune, The Wall Street Journal, Harvard Business Review, The New York Times, Forbes, The New Yorker, WIRED, and Fast Company.

Kathy received her MBA in general management from Harvard Business School and holds an honorary Doctorate from the University of Vermont.

Stefan Oelrich

Member of the Board of Management, Bayer AG, President Pharmaceuticals

Stefan Oelrich is a member of the Board of Management of Bayer AG and President of its Pharmaceuticals Division, a position he has held since November 2018.

Prior to joining the company, he was on the Executive Committee of Sanofi, leading its global Diabetes & Cardiovascular business. During his seven-year tenure, he was also at the helm of Sanofi Germany, Switzerland and Austria, as well as the Diabetes and Cardiovascular business unit in Europe.

From 1989 to 2011, Mr. Oelrich held various leadership positions in the health care business of Bayer AG with extensive international experience spanning Latin America (Argentina, Uruguay), Europe (France, Belgium) and the United States.

Mr. Oelrich is a member of the Supervisory Board of the university hospital Charité, member of the Supervisory Board of the Berlin Institute of Health and member of the Board of the American Chamber of Commerce in Germany.

Christophe Weber

President and Chief Executive Officer, Takeda Pharmaceutical Company Limited

Christophe Weber is President, Chief Executive Officer (CEO) and Representative Director of Takeda Pharmaceutical Company Ltd. He joined the company in April 2014 as Chief Operating Officer, was named President and Representative Director in June 2014, and was subsequently appointed CEO in April 2015. Mr. Weber has focused on Takeda’s R&D transformation and globalization, creating a diverse and inclusive working environment while strengthening its ethical values and corporate governance. Through this transformation, Takeda became one of the leading global biopharmaceutical companies in the world.

Prior to joining Takeda, Mr. Weber spent 20 years at GlaxoSmithKline (GSK), where he held senior leadership roles in Europe, Asia and the United States.

Outside of Takeda, Mr. Weber is member of The Business Council, the World Economic Forum’s International Business Council, the Singapore Economic Development Board’s International Advisory Council, the New York Stock Exchange’s NYSE Board Advisory Council and the MIT CEO Advisory Board. He also serves on the Board of Trustees of Northeastern University.

Mr. Weber holds a doctorate in pharmacy and pharmacokinetics, master’s degrees in pharmaceutical marketing and in accounting and finance and a degree in statistics, from the University of Lyon, France.

Mr. Weber lives in Tokyo with his wife and has two children.

Steve Peretz

Director, Health Experience & Product Strategy at Appnovation

Steve brings nearly 15 years of healthcare experience working with pharma brands, CPG wellness, and change management platforms. Successfully navigating through such a highly-regulated industry brings its own unique challenges, but he has the experience to tackle them head-on and knows that digital has the power to transform the healthcare landscape and bring ambitious new ideas to life.

Anton Morrison

VP of User Experience & Design at Appnovation

A user design and experience expert, Anton believes that groundbreaking human-centric journeys are borne from the intersection of creativity and strategy.

Groundbreaking results require holistic new ways of working. After more than 15 years of leading multi-faceted, cross-functional digital teams to deliver large scale, customer-centric projects for clients including BBC, Nissan, Pfizer and Visit California, Anton believes that siloes needed to be broken down to free our thinking. A passionate customer advocate, he aims to show clients and partners that an intelligent and purposeful mix of design thinking and business strategy makes people feel deep emotional connections that drive them to action.

Ashwini Zenooz

MD, GM & Chief Medical Officer, Salesforce

Dr. Zenooz was most recently the Chief Medical Officer at the Department of Veterans Affairs (VA) overseeing the national EHR modernization program. She has also held senior policy development and operational roles including serving as Deputy for VA Health Policy and Services, Legislative Health Policy Fellow with U.S. Senator Richard Blumenthal, Committee Staff on U.S. Senate Committee on Veterans Affairs, and Chief of Imaging Services.

Dr. Zenooz received her MD in the Medical Honors Program at the University of Florida. She completed radiology residency at Henry Ford Health System and an Abdominal Imaging fellowship at Massachusetts General Hospital. Dr. Zenooz is board certified in radiology and continues to practice medicine today.

Aaron Turner-Phifer

Vice President, Government Relations and Policy, URAC

Aaron Turner-Phifer serves as the Vice President of Government Relations and Policy, for URAC, an independent health care accreditation organization located in Washington, DC and the only digital health accreditor in the United States. He has extensive experience advising and crafting public policy at the federal, state, and local levels. He has experience working on health care quality initiatives and public policy that impacts Medicare, Medicaid, and Health Insurance Marketplace enrollees, that often inform broader policies that affect the public at large. His recent work includes leading creation of national health care policy for permanent, safe and secure digital health growth to ensure that patients have access to the care they need whether in person or through telehealth/remote patient monitoring. He is an expert political and policy analyst with a unique understanding of the intricacies associated with the development of health care policy and can often be seen presenting at policy meetings before Congress or on television explaining health care policies to larger audiences. He achieved his Master of Health Administration degree from the George Washington University.

Dr. Greg Moore

Corporate Vice President, Microsoft Health

Moore will be taking on the responsibility to shepherd the dedicated research and development collaborations with our strategic partners, such as Walgreens Boots Alliance, to deliver next-generation technologies and experiences for healthcare. He will bring into these partnerships the new AI and machine learning solutions that are being developed across Microsoft, to enable personalized care and empower care teams. He will help provide internal and external thought leadership that can lead to a more open, interoperable, and AI-infused foundation for healthcare delivery.

Dr. Gregory J. Moore is an engineer (MIT PhD), practicing neuroradiologist, clinical informaticist, and innovator experienced in assembling and inspiring highly talented teams to positively transform healthcare for the benefit of humankind. Prior to joining Microsoft, Greg was Vice President Google Inc, Google Cloud Healthcare & Life Sciences. In this role, Greg founded and led the healthcare vertical for Google Cloud and partnered closely with various Google teams and the Alphabet companies in the life sciences domains to guide and develop innovative healthcare products and solutions leveraging AI, machine learning and advanced analytics at scale.

Greg is board certified in Diagnostic Radiology, Neuroradiology and Clinical Informatics and is also an Adjunct Clinical Professor of Radiology at Stanford University School of Medicine. Prior to his leadership appointment at Google, he was Chief Emerging Technology and Informatics Officer at Geisinger Health System where he also was Director of the Institute for Advanced Application.

Moore received his Master of Science (MS), Nuclear Engineering in 1988, and his Doctor of Philosophy (PhD) in Radiological Sciences in 1992 (both from Massachusetts Institute of Technology). He went on to receive his Doctor of Medicine (MD) in 2004 from Wayne State University School of Medicine and completed residency in Diagnostic Radiology and Fellowship in Neuroradiology, both at Penn State University Hershey Medical Center.

Bill Stith

SVP and Global Head, Health Business Unit, Wipro

Bill is a senior Healthcare and Technology Executive with over 27 years of experience in Healthcare, Life Sciences, and Technology domains. He has executive leadership experience in business development, product management, software development, consulting and managed services.

Bill joined Wipro from IBM Global Services where, as Vice President of Healthcare and Life Sciences, he was responsible for IBM’s US business with full P&L, Sales, Marketing and Delivery responsibilities.Bill spent the initial part of his career with HealthQuest which was later acquired by McKesson Health IT and following that has had a variety of leadership roles in the Healthcare and Technology sectors with Dell, LeftHand Networks (acquired by HP), SunGard and Dimension Data.

Bill is an Electrical and Computer Engineer from University of South Carolina and currently lives in Denver, where he enjoys being outdoors in the mountains with his wife and three children.

Ramona Sequeira

President, Takeda Pharmaceuticals U.S.A

Ramona Sequeira is President of Takeda Pharmaceuticals U.S.A., Inc., leading the U.S. Business Unit for Takeda and President of Global Portfolio Commercialization while serving as a member of Takeda’s global Executive Team. She joined Takeda in 2015.

Prior to joining Takeda, Ms. Sequeira held a number of roles with increasing responsibly at Eli Lilly, including Vice President of Sales and Operations and Vice President of the Neuroscience Business Unit. She is a member of the PhRMA Board of Directors and was recently appointed Treasurer of the Board. Before that, Ms. Sequeira served as Chair of PhRMA’s State Committee. She also sits on the Board of the Plasma Protein Therapeutics Association (PPTA) in Annapolis, Maryland.

Ms. Sequeira holds a Master’s in Business Administration from McMaster University in Canada and a B.S. in Molecular Genetics and Molecular Biology from the University of Toronto.

Ms. Sequeira lives in Boston with her husband Doug and has two children.

Dr Bimal Shah

Teladoc Health Chief Medical Officer, Product & Analytics, Livongo

Dr. Bimal Shah is responsible for Livongo’s strategic clinical product vision, clinical content, and clinical research and analytics. Dr. Shah previously served as the company’s Senior Vice President for Clinical and Strategic Partnerships, where he provided clinical guidance and launched Livongo first cardiovascular product offering, assisted in strategic pursuits, and explored opportunities to expand Livongo’s offerings into other parts of the healthcare market. Prior to Livongo, Dr. Shah was the Service Line Vice President at Premier, Inc for its real-world evidence business. Prior to Premier, Dr. Shah served as an Assistant Professor at Duke University, where he held numerous leadership positions in research programs and clinical administration. Dr. Shah graduated from the University of North Carolina – Chapel Hill with the highest honors and earned both a Doctor of Medicine and Masters in Business Administration from Duke University. Dr. Shah completed his residency in Internal Medicine at Stanford University before finishing a General Cardiology fellowship at Duke University. He is also a member of both the Board of Advisors for the Duke School of Nursing and Board of Visitors for the University of North Carolina – Chapel Hill. Dr. Shah is a practicing cardiologist.

Michael Greenberg

Vice President, Regional Medical Head, North America, Sanofi Pasteur

More info coming soon.

David Houghton

System Chair, Telemedicine, Ochsner Health

More info coming soon.

Martin Doerfler

SVP, Clinical Strategy and Development, Northwell Health

More info coming soon.

Esther Schorr

Co-Founder, Chief Operating Officer, Patient Power

More info coming soon.

Axel Threfall

Editor-at-large, Reuters

Axel Threlfall is Editor-at-Large, Reuters, based in London. Alongside his editorial duties, he hosts high-profile engagements and thought leadership events for and on behalf of Reuters and Thomson Reuters, such as the Newsmaker series and the World Economic Forum news programming in Davos. He was previously Lead European Anchor for Reuters Digital Video. Prior to joining Reuters, Axel spent five years as an anchor for CNBC in London. Before that, he was an editor with The Wall Street Journal in New York and a news reporter for Bloomberg in London. He has also advised businesses and NGOs on their dealings with the international media. Axel is frequently asked to moderate events for international organizations, including the United Nations, the IMF and the OECD. He has a BA in History from Durham University and a postgraduate degree in journalism from City University, London.

Twitter handle is: @Axelthrelfall

Julie Steenhuysen

Health and Science Correspondent, Reuters News

More info coming soon.

Larry St Onge

President, Life Sciences and Healthcare, DHL

More info coming soon.

Andrew Dunn

Business Insider

More info coming soon.

Dr. Susan S. Garfield

US Consulting Principal and Life Sciences Sector, EY

An accomplished strategist, consultant, and thought leader, Susan leads the commercial team within EY Life Sciences Consulting and strategy teams.

Her career in life sciences spans 20 years. Prior to joining EY in 2015, she held various executive positions at consulting firms and life sciences and healthcare companies.

Currently, she works with our life sciences clients on pioneering strategies and commercial transformation programs.

She received a DrPH in Health Policy and Management from Boston University’s School of Public Health and an SM in Health Policy and Management from Harvard TH Chan School of Public Health. She also has an MSc in Population and Development from The London School of Economics and Political Science and a BA in English and Women’s Studies from the University of Pennsylvania.

How Susan is building a better working world

By mentoring team members, Susan is helping to develop the next generation of consulting leaders at EY.

She is also a regular speaker and published writer on the future of commercial life sciences.

In addition, she sits on several boards, including Boston University School of Public Health and Temple Shir Tikva, along with several other service roles.

Dr Amy Abernethy

Principal Deputy Commissioner, FDA

More info coming soon.

Neil de Crescenzo

CEO, ChangeHealthcare

Neil de Crescenzo is president and chief executive officer of Change Healthcare and a member of the company’s board of directors. He leads teams working across multiple healthcare segments to help customers achieve their clinical, operational, and financial objectives, as well as providing solutions to customers that enable them to better help people maintain or improve their health.

Before joining Change Healthcare, Mr. de Crescenzo was senior vice president and general manager of Oracle's Global Health Sciences business. Prior to joining Oracle in 2006, he spent a decade at IBM Corporation, including his last role as a senior executive for Global Healthcare Business Consulting Services. Earlier in his career, he held leadership positions in a major hospital system, a large multi-specialty group practice, and at a major health insurer.

Mr. de Crescenzo earned a B.A. in political science from Yale University and an M.B.A. from Northeastern University. He currently serves on the board of directors of the Nashville Health Care Council, the Middle Tennessee American Heart Association, and is chairman of the executive committee of the board of directors of the Healthcare Leadership Council. He is a member of the Aspen Group.

Brandon M. Welch, MS, PhD

Founder and CEO, doxy.me

More info coming soon.

Joshua Newman, MD MSHS

SVP Healthcare and Life Sciences, Salesforce

More info coming soon.

Mark Crossley

Chief Executive Officer, Indivior

Mark was appointed Chief Executive Officer in June 2020.

Mark was appointed to the Board and as Chief Financial Operations in February 2017. In July 2019, Mark took on additional responsibilities and was appointed Chief Financial and Operations Officer in July 2019, with oversight of the finance, information technology, manufacturing, supply, quality and procurement functions.

He joined the Company in 2012 as the Global Finance Director with responsibilities for Finance, Information Systems and Procurement. He was appointed Chief Strategy Officer in October 2014.

Prior to joining Indivior, Mark spent 13 years at Procter & Gamble in various finance leadership roles including Corporate Portfolio, Strategic and Business Planning (Female Beauty), as well as, multiple roles in Corporate Treasury and its Baby Care division. He also enjoyed an eight-year career with various operational and staff assignments in the United States Coast Guard.

Mark graduated from the United States Coast Guard Academy with a BS in Management and Economics, and from Boston College with an MBA.